抗癌化疗耐药性:针对性药物输送的机制和最近的突破
Fatemeh Davodabadi1, Seyedeh Fatemeh Sajjadi2, Mohammad Sarhadi3
1Department of Biology, Faculty of Basic Science, Payame Noor University, Tehran, Iran.
European journal of pharmacology
|August 26, 2023
概括
纳米粒子 (NP) 通过向耐药性和增强药物输送来改善癌症治疗. 评估纳米载体挑战对于推进这种创新的纳米药物疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 传统化疗面临的局限性包括严重的副作用,耐药性和瘤部位的药物度低下.
- 系统化疗的缺点需要新的方法来提高癌症治疗效率和克服抵抗机制.
- 使用纳米粒子 (NP) 的向药物递送已经成为解决这些挑战的关键策略.
研究的目的:
- 探索纳米粒子 (NP) 在克服癌症治疗耐药性和改善治疗结果方面的潜力.
- 突出基于NP的药物递送系统在癌症治疗中的好处,包括增强的药理动力学和有针对性的递送.
- 强调评估与纳米载体技术相关的局限性和挑战的关键需求.
主要方法:
- 关于纳米粒子在癌症治疗中的应用现有文献的综述.
- 分析NP向瘤治疗抵抗路径的机制.
- 评估基于NP的药物输送系统的优缺点.
主要成果:
- 基于NP的药物递送系统显示出显著的益处,包括改善药理动力学和瘤细胞特定向.
- 瘤疗法有效地准瘤治疗耐药性的各种机制,从而导致潜在的更好的治疗结果.
- 纳米药物的应用有助于更精确的瘤诊断,治疗和向.
结论:
- 纳米颗粒是一种有前途的创新技术,有可能显著推进癌症治疗.
- 了解NP技术的局限性和挑战对于有效的纳米载体评估和临床转化至关重要.
- 基于NP的系统为减少癌症治疗中的副作用和降低抗药性提供了一条途径.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
13.4K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
